This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Lee Edwin Lowrie, Jr. - Innovator in Thiazolopyrimidine Compounds
Introduction
Lee Edwin Lowrie, Jr. is an accomplished inventor based in Andover, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of thiazolopyrimidine compounds. His work focuses on creating novel derivatives that serve as SYK inhibitors, which are essential for treating auto-immune and inflammatory diseases.
Latest Patents
Lee Edwin Lowrie, Jr. holds a patent for thiazolopyrimidine compounds. The patent details the use of these innovative compounds, which are defined by a specific formula, and highlights their potential therapeutic applications.
Career Highlights
Lowrie is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His role at the company has allowed him to contribute to groundbreaking research and development in the field of medicinal chemistry.
Collaborations
Throughout his career, Lowrie has collaborated with notable colleagues, including Johannes Cornelius Hermann and Matthew C. Lucas. These partnerships have fostered an environment of innovation and creativity in their research endeavors.
Conclusion
Lee Edwin Lowrie, Jr. exemplifies the spirit of innovation in the pharmaceutical industry through his work on thiazolopyrimidine compounds. His contributions are paving the way for new treatments for auto-immune and inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile